Differently from cardiac transplantation, high dosage riboflavin treatment improves not only heart function, but it also impacts the other organs affected in ACAD9 deficiency (e.g., muscular, neurologic, renal systems, etc.)(108). Here, ACAD9 is linked to hyperinsulinemic hypoglycemia, familial, 4.